Wednesday, 4 April 2012

Novel : Highly Sensitive Diagnostic for Non-Alcoholic Fatty Liver Disease...

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the Western population and is increasing in prevalence.  There exists an urgent unmet need for the development of non-invasive methods of staging and grading NAFLD to allow early targeted therapy.

Researchers at the University of Dundee have developed a novel, highly sensitive diagnostic tool for Non-Alcoholic Fatty Liver Disease (NAFLD). Capable of distinguishing between the disease states of NAFLD, the system presents a unique opportunity to allow early intervention and monitoring of disease state.

Their test will allow large populations to be easily and cost-effectively screened for the presence of NASH and appropriate therapy implemented.  The panel of markers could also have utility as confirmation of therapeutic efficacy and could be developed as surrogate markers for end points in the evaluation of new therapeutic agents.